HomeInsightsPB

Windlas Biotech Ltd PB Ratio

Windlas Biotech Ltd PB Ratio

stocks purchased

₹ 0.3 Cr

Volume transacted

stocks purchased

2.9 K

stocks traded

Last Updated time: 18 Sep 9.00 AM

Image

Windlas Biotech Ltd

NSE: WINDLAS

PB

4

Last updated: 18 Sep 24

Key Highlights

  • The P/B Ratio of Windlas Biotech Ltd is 4 as of 18 Sep 24.
  • The P/B Ratio of Windlas Biotech Ltd changed from 1.2 on March 2022 to 2.4 on March 2024 . This represents a CAGR of 25.99% over 3 years. .

Historical P/B Ratio of Windlas Biotech Ltd

No data available

Company Fundamentals for Windlas Biotech Ltd

Market Cap

1,819 Cr

EPS

28.5

P/E Ratio (TTM) *

30.5

P/B Ratio (TTM) *

4.0

Day’s High *

894.95

Day’s Low

865.7

DTE *

0.0

ROE *

12.9

52 Week High

950.0

52 Week Low

308.35

ROCE *

17.2

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Windlas Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
18 Sep 2024870.75
17 Sep 2024894.95
16 Sep 2024885.25
13 Sep 2024906.7
12 Sep 2024895.75
11 Sep 2024910
10 Sep 2024887.75
09 Sep 2024899.7
06 Sep 2024900.65
05 Sep 2024904.3

SWOT Analysis Of Windlas Biotech Ltd

Strength

5

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Windlas Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Windlas Biotech Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/B Ratio

Company NamePBMarket Cap (INR Cr.)
Windlas Biotech Ltd41,819
Sun Pharmaceuticals Industries Ltd984,39,714
Divis Laboratories Ltd5071,45,166
Cipla Ltd3461,33,402
Torrent Pharmaceuticals Ltd2011,13,724
Dr Reddys Laboratories Ltd14581,09,604

Key Valuation Metric of Windlas Biotech Ltd

The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share.


How to calculate Price-to-Book (P/B) Ratio?

The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company.


Market capitalization = market value of a stock X no. of outstanding shares


Now, you need to know the net value of an organization's assets.

Book Value of Assets = Total Assets - Total Liabilities of a company


After knowing the value of the above ratios, here is the formula for the P/B Ratio:

P/B Ratio = Market Capitalization/ Book Value of Assets


or you can also use this formula

P/B ratio = Market Price Per Share/ Book Value of Asset Per Share

Historical Market Cap of Windlas Biotech Ltd

No data available

* All values are in crore

Historical Revenue of Windlas Biotech Ltd

No data available

* All values are in crore

Historical EBITDA of Windlas Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Windlas Biotech Ltd

No data available

* All values are in crore

Dividend per Share (DPS) Over Time

No data available

Windlas Biotech Ltd News Hub

News

Windlas Biotech schedules AGM

Windlas Biotech announced that the Annual General Meeting (AGM) of the company will be hel...

Read more

03 Sep 202417:28

News

Windlas Biotech to hold AGM

Windlas Biotech announced that the Annual General Meeting (AGM) of the company will be hel...

Read more

03 Sep 202411:39

News

Windlas Biotech to declare Quarterly Result

Windlas Biotech will hold a meeting of the Board of Directors of the Company on 13 August ...

Read more

03 Aug 202414:35

News

Board of Windlas Biotech recommends final dividend

Windlas Biotech announced that the Board of Directors of the Company at its meeting held o...

Read more

20 May 202415:14

News

Windlas Biotech to announce Quarterly Result

Windlas Biotech will hold a meeting of the Board of Directors of the Company on 20 May 202...

Read more

11 May 202412:29

News

Windlas Biotech commissions its injectable facility

Windlas Biotech announced the commissioning of its state-of-the-art injectable facility fo...

Read more

02 Apr 202413:30

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PB Ratio of Windlas Biotech Ltd

What is the PB ratio of Windlas Biotech Ltd?

The current PB ratio of Windlas Biotech Ltd is 4.04. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Windlas Biotech Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Windlas Biotech Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Windlas Biotech Ltd calculated?

The PB ratio of Windlas Biotech Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Windlas Biotech Ltd?

A high PB ratio suggests that Windlas Biotech Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Windlas Biotech Ltd?

A low PB ratio of Windlas Biotech Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Windlas Biotech Ltd PB Ratio change over time?

Yes, the PB ratio of Windlas Biotech Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*